Roma, 6 dicembre 2023 – Cube Labs S.p.A. (“Cube Labs” o “Società”) - venture builder italiano nel settore delle tecnologie healthcare e quotata sul mercato Euronext Growth Milan, segmento Professionale…
Milano, 1 dicembre 2023 – Filippo Surace, fondatore e CEO di Cube Labs – il venture builder italiano nel settore delle Tecnologie Healthcare quotato su EGM Pro – ha ricevuto…
Roma, 2 novembre 2023 – Cube Labs è lieta di annunciare la partecipazione all’evento “Promuovere l’innovazione nelle Scienze della Vita - Friuli Venezia Giulia, The place to be”, appuntamento di…
Rome, 3 April 2023 - Cube Labs S.p.A., an Italian venture builder in the healthcare technology space, and IBI (Istituto Biochimico Italiano G. Lorenzini Spa), an international biopharmaceutical company specializing…
Milano – 21 marzo 2023 – Borsa Italiana, parte del Gruppo Euronext, dà oggi il benvenuto a Cube Labs sul Segmento Professionale di Euronext Growth Milan.Cube Labs è un “venture…
SUCCESSFULLY CONCLUDED THE PLACEMENT AMOUNTING TO € 4,105,000, AT THE OFFER PRICE OF € 2.00 PER SHARE.TRADING TO BEGIN ON 21 MARCH 2023 Rome, March 17th, 2023 - Cube Labs…
Rome, March 15th, 2023 - Cube Labs S.p.A. ("Cube Labs" or the "Company") - an Italian venture builder in the healthcare technology sector - announced that it has submitted to…
Rome 6 March 2023 - Cube Labs S.p.A. (“Cube Labs” or “Company”) - an Italian venture builder specializing in healthcare technologies - has announced that it has initiated the listing…
27 February 2023ROME, Italy Cartilago SRL (”Cartilago”), a clinical stage regenerative medicine company founded by Cube Labs, announced today that the United States Patent & Trademark Office (”USPTO”) has issued…
Under the patronage of the Presidency of the Council of Ministers of Italy, Cube Labs has been recognized by Associazione Liber as among "100 Italian Excellences." The recognition was conferred…